Curriculum
INFORMAZIONI PERSONALI
Nome PETRACCA MARIA
Orcid ID 0000-0001-9429-2769
Scopus Author ID 24477713600
Web of Science Researcher ID AAB-8562-2019
ESPERIENZA LAVORATIVA
•DA FEBBRAIO 2021– AD OGGI Ricercatrice a tempo determinato – Dipartimento di Neuroscienze Umane, Università degli Studi di Roma La Sapienza
•DICEMBRE 2019– NOVEMBRE 2020 Assegnista di Ricerca - Dipartimento di Neuroscienze, Scienze Riproduttive ed Odontostomatologiche
Università degli Studi di Napoli Federico II
Progetto: "Identificazione di biomarcatori di progressione in Sclerosi Multipla da sequenze RM standard"
• GIUGNO 2016 – FEBBRAIO 2019 Ricercatrice Post-Dottorato - Icahn School of Medicine at Mount Sinai, New York
Progetto: "Applicazione di tecniche di neuroimaging avanzato per la caratterizzazione di processi patogenetici in pazienti con Sclerosi Multipla."
• GIUGNO 2014 – GIUGNO 2016 Borsista di Ricerca - Icahn School of Medicine at Mount Sinai, New York
Progetto: “Quantificazione delle concentrazioni intra- ed extracellullari di sodio encefalico in pazienti con Sclerosi Multipla mediante RM a 7.0 Tesla” (Fondazione Italiana Sclerosi Multipla-Borsa di Ricerca FISM 2013/B/7).
• AGOSTO 2013 – OTTOBRE 2013. Assegnista di Ricerca - Icahn School of Medicine at Mount Sinai, New York
Progetto: "Acquisizione ed analisi di sequenze RM avanzate, con particolare focus su diffusion tensor imaging (DTI) e functional MRI."
• MARZO 2008 – MARZO 2013 Medico in formazione specialistica - A.O.U. Federico II, Dipartimento di Scienze Neurologiche. Divisione di Patologia Speciale Neurologica e Malattie Neurodegenerative.
• MAGGIO 2012 - NOVEMBRE 2012 Visiting researcher - Icahn School of Medicine at Mount Sinai, New York
Progetto: "Acquisizione ed analisi di sequenze RM avanzate, con particolare focus su double inversion recovery (DIR)."
• MAGGIO 2012 - NOVEMBRE 2012 Visiting researcher - The Chiari Institute-North Shore LIJ Medical group
Diagnosi e gestione terapeutica di Malformazione di Chiari Tipo I, Siringomielia, Impressione basilare, Midollo ancorato, Instabilità cranio-cervicale e disturbi correlati.
ISTRUZIONE E FORMAZIONE
• APRILE 2013- APRILE 2016 Dottorato di Ricerca in Neuroscienze - Università degli Studi di Napoli Federico II.
Conseguimento del titolo in data 21/04/2016. Progetto di tesi: “Quantificazione delle concentrazioni intra- ed extra-cellullari di sodio encefalico in pazienti con Sclerosi Multipla mediante RM a 7.0 Tesla”
• MARZO 2008 - MARZO 2013 Specializzazione in Neurologia - Università degli Studi di Napoli Federico II. Dipartimento di Scienze Neurologiche.
Conseguimento del titolo in data 19/03/2013, 50/50 lode e menzione. Progetto di tesi: “Pattern di coinvolgimento della Sostanza Grigia in pazienti Afro-Americani affetti da Sclerosi Multipla.”
• OTTOBRE 2001 - LUGLIO 2007 Laurea in Medicina e Chirurgia - Università degli Studi di Napoli Federico II.
Conseguimento del titolo in data 20/07/2007, 110/110 e lode. Progetto di tesi: “Sclerosi Multipla e ormoni sessuali femminili: valutazione del pattern ormonale e correlazione con i parametri clinici della patologia.”
FINANZIAMENTI
• Borsa di ricerca Fondazione Italiana Sclerosi Multipla (FISM). Progetto: “Quantificazione delle concentrazioni intra- ed extracellullari di sodio encefalico in pazienti con Sclerosi Multipla mediante RM a 7.0 Tesla” (FISM 2013/B/7). Ruolo: trainee. Mentore: Matilde Inglese.
• Ministero della Salute - bando ricerca finalizzata 2019 – giovani ricercatori (GR-2019-12370095). Progetto: “ERMES: Exergaming for cognitive Rehabilitation in MultiplE Sclerosis: a randomized trial to test efficacy and a machine learning approach to drive prescription”. Ruolo: collaboratrice. PI: Serena Ruggieri. Co-PI: Silvia Tommasin.
COLLABORAZIONI INTERNAZIONALI
Membro del gruppo International Women in MS dal 2018.
PUBBLICAZIONI – Articoli su riviste internazionali
1) Carotenuto A, Costabile T, Pontillo G, Moccia M, Falco F, Petracca M, Petruzzo M, Russo CV, Di Stasi M, Paolella C, Perillo T, Vola EA, Cipullo MB, Cocozza S, Lanzillo R, Brescia Morra V, Saccà F. Cognitive trajectories in multiple sclerosis: a long-term follow-up study. Neurol Sci. 2021 Jun 8. Online ahead of print.
2) Tommasin S, Cocozza S, Taloni A, Giannì C, Petsas N, Pontillo G, Petracca M, Ruggieri S, De Giglio L, Pozzilli C, Brunetti A, Pantano P. Machine learning classifier to identify clinical and radiological features relevant to disability progression in multiple sclerosis. J Neurol. 2021 May 10. Online ahead of print.
3) Carotenuto A, Costabile T, Moccia M, Falco F, Petracca M, Satelliti B, Russo CV, Sacc F, Lanzillo R, Brescia Morra V. Interplay Between Cognitive and Bowel/Bladder Function in Multiple Sclerosis. Int Neurourol J. 2021 May 6. Online ahead of print.
4) Ruggieri S, Petracca M, De Giglio L, De Luca F, Giannì C, Gurreri F, Petsas N, Tommasin S, Pozzilli C, Pantano P. A matter of atrophy: differential impact of brain and spine damage on disability worsening in multiple sclerosis. J Neurol. 2021 May 3. Online ahead of print.
5) Reia A, Petruzzo M, Falco F, Costabile T, Conenna M, Carotenuto A, Petracca M, Servillo G, Lanzillo R, Brescia Morra V, Moccia M. A Retrospective Exploratory Analysis on Cardiovascular Risk and Cognitive Dysfunction in Multiple Sclerosis. Brain Sci. 2021 Apr 16;11(4):502
6) Pontillo G, Petracca M, Monti S, Quarantelli M, Criscuolo C, Lanzillo R, Tedeschi E, Elefante A, Brescia Morra V, Brunetti A, Cocozza S, Palma G. Unraveling Deep Gray Matter Atrophy and Iron and Myelin Changes in Multiple Sclerosis. AJNR Am J Neuroradiol. 2021 Apr 22. Online ahead of print.
7) Zanghì A, Gallo A, Avolio C, Capuano R, Lucchini M, Petracca M, Bonavita S, Lanzillo R, Ferraro D, Curti E, Buccafusca M, Callari G, Barone S, Pontillo G, Abbadessa G, Di Francescantonio V, Signoriello E, Lus G, Sola P, Granella F, Valentino P, Mirabella M, Patti F, D'Amico E. Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study. Neurotherapeutics. 2021 Apr 12. Online ahead of print.
8) Vola EA, Petracca M, Cocozza S, De Angelis M, Carotenuto A, Pontillo G, Morra VB, Tedeschi E, Lanzillo R. Possible progressive multifocal leukoencephalopathy and active multiple sclerosis under dimethyl fumarate: the central role of MRI in informing therapeutic decisions. BMC Neurol. 2021 Apr 5;21(1):146
9) Sormani MP, De Rossi N, Schiavetti I, Carmisciano L, Cordioli C, Moiola L, Radaelli M, Immovilli P, Capobianco M, Trojano M, Zaratin P, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M; Musc-19 Study Group. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis. Ann Neurol. 2021 Apr;89(4):780-789.
10) Carotenuto A, Scandurra C, Costabile T, Lavorgna L, Borriello G, Moiola L, Inglese M, Trojsi F, Petruzzo M, Ianniello A, Nozzolillo A, Cellerino M, Boffa G, Rosa L, Chiodi A, Servillo G, Moccia M, Bonavita S, Filippi M, Petracca M, Brescia Morra V, Lanzillo R. Physical Exercise Moderates the Effects of Disability on Depression in People with Multiple Sclerosis during the COVID-19 Outbreak. J Clin Med. 2021 Mar 16;10(6):1234.
11) Petracca M, Pontillo G, Moccia M, Carotenuto A, Cocozza S, Lanzillo R, Brunetti A, Brescia Morra V. Neuroimaging Correlates of Cognitive Dysfunction in Adults with Multiple Sclerosis. Brain Sci. 2021 Mar 9;11(3):346.
12) Cellerino M, Priano L, Bruschi N, Boffa G, Petracca M, Novi G, Lapucci C, Sbragia E, Uccelli A, Inglese M. Relationship Between Retinal Layers Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis. J Neuroophthalmol. 2020 Dec 29;Publish Ahead of Print.
13) Capasso N, Palladino R, Montella E, Pennino F, Lanzillo R, Carotenuto A, Petracca M, Iodice R, Iovino A, Aruta F, Pastore V, Buonomo AR, Zappulo E, Gentile I, Triassi M, Brescia Morra V, Moccia M. Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg. J Clin Med. 2020 Dec 16;9(12):4066.
14) Schiavi S*, Petracca M*, Sun P, Fleysher L, Cocozza S, El Mendili MM, Signori A, Babb JS, Podranski K, Song SK, Inglese M. Non-invasive quantification of inflammation, axonal and myelin injury in multiple sclerosis. Brain. 2020 Nov 30:awaa381. doi: 10.1093/brain/awaa381. Online ahead of print.
15) Carotenuto A, De Giglio L, Chiodi A, Petracca M, Rosa L, Bianchi M, Ferrante I, Lauro F, Moccia M, Ianniello A, Pozzilli C, Brescia Morra V, Lanzillo R. Validation of the Italian version of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-19. Neurol Sci. 2020 Nov 21. doi: 10.1007/s10072-020-04873-w. Online ahead of print.
16) Petracca M, El Mendili MM, Moro M, Cocozza S, Podranski K, Fleysher L, Inglese M. Laminar analysis of the cortical T1/T2-weighted ratio at 7T. Neurol Neuroimmunol Neuroinflamm. 2020 Oct 21;7(6):e900
17) Costabile T, Carotenuto A, Lavorgna L, Borriello G, Moiola L, Inglese M, Petruzzo M, Trojsi F, Ianniello A, Nozzolillo A, Cellerino M, Boffa G, Rosa L, Servillo G, Moccia M, Bonavita S, Filippi M, Lanzillo R, Brescia Morra V, Petracca M. COVID-19 pandemic and mental distress in Multiple Sclerosis: implications for clinical management. Eur J Neurol. 2020 Oct 11. doi: 10.1111/ene.14580. Online ahead of print.
18) Amatruda M, Petracca M, Wentling M, Inbar B, Castro K, Chen EY, Kiebish MA, Edwards K, Inglese M, Casaccia P. Retrospective unbiased plasma lipidomic of progressive multiple sclerosis patients-identifies lipids discriminating those with faster clinical deterioration. Sci Rep. 2020 Sep 24;10(1):15644.
19) Martino M, Magioncalda P, El Mendili MM, Droby A, Paduri S, Schiavi S, Petracca M, Inglese M. Depression is associated with disconnection of neurotransmitter-related nuclei in multiple sclerosis. Mult Scler. 2020 Sep 10:1352458520948214.
20) De Angelis M, Petracca M, Lanzillo R, Brescia Morra V, Moccia M. Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice. Mult Scler Relat Disord. 2020 Aug 16;45:102452.
21) Pontillo G, Petracca M, Cocozza S, Brunetti A. The Development of Subcortical Gray Matter Atrophy in Multiple Sclerosis: One Size Does Not Fit All. AJNR Am J Neuroradiol. 2020 Jul 9. doi: 10.3174/ajnr.A6698. Online ahead of print.
22) Cennamo G, Carotenuto A, Montorio D, Petracca M, Moccia M, Melenzane A, Tranfa F, Lamberti A, Spiezia AL, Servillo G, De Angelis M, Petruzzo M, Criscuolo C, Lanzillo R, Brescia Morra V. Peripapillary Vessel Density as Early Biomarker in Multiple Sclerosis. Front Neurol. 2020 Jun 17;11:542
23) Sormani MP; Italian Study Group on COVID-19 infection in multiple sclerosis. An Italian programme for COVID-19 infection in multiple sclerosis. Lancet Neurol. 2020 Jun;19(6):481-482.
24) Droby A, Fleysher L, Petracca M, Podranski K, Xu J, Fabian M, Marjańska M, Inglese M. Lower cortical gamma-aminobutyric acid level contributes to connectivity in sensory-motor inter-connected regions in progressive MS. Mult Scler Relat Disord. 2020 Aug;43:102183.
25) Schiavi S*, Petracca M*, Battocchio M, El Mendili MM, Paduri S, Fleysher L, Inglese M, Daducci A. Sensory-motor network topology in multiple sclerosis: Structural connectivity analysis accounting for intrinsic density discrepancy. Hum Brain Mapp. 2020 Aug 1;41(11):2951-2963.
26) Fox E, Lovett-Racke AE, Gormley M, Liu Y, Petracca M, Cocozza S, Shubin R, Wray S, Weiss MS, Bosco JA, Power SA, Mok K, Inglese M. A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis. Mult Scler. 2020 Apr 30:1352458520918375. doi: 10.1177/1352458520918375. [Epub ahead of print]
27) Petracca M, Schiavi S, Battocchio M, El Mendili MM, Fleysher L, Daducci A, Inglese M. Streamline density and lesion volume reveal a postero-anterior gradient of corpus callosum damage in multiple sclerosis. Eur J Neurol. 2020 Jun;27(6):1076-1082.
28) Pontillo G, Cocozza S, Di Stasi M, Carotenuto A, Paolella C, Cipullo MB, Perillo T, Vola EA, Russo C, Masullo M, Moccia M, Lanzillo R, Tedeschi E, Elefante A, Brescia Morra V, Brunetti A, Quarantelli M, Petracca M. 2D linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosis. Eur Radiol. 2020 Jul;30(7):3813-3822.
29) El Mendili MM, Petracca M, Podranski K, Fleysher L, Cocozza S, Inglese M. SUITer: an automated method for improving segmentation of infratentorial structures at ultra-high field MRI. J Neuroimaging 2020 Jan;30(1):28-39.
30) Wentling M, Lopez-Gomez C, Park HJ, Amatruda M, Ntranos A, Aramini J, Petracca M, Rusielewicz T, Chen E, Tolstikov V, Kiebish M, Fossati V, Inglese M, Quinzii CM, Katz Sand I, Casaccia P. A metabolic perspective on CSF-mediated neurodegeneration in multiple sclerosis. Brain. 2019 Sep 1;142(9):2756-2774.
31) Margoni M, Petracca M, Schiavi S, Fabian M, Miller A, Lublin FD, Inglese M. Axonal water fraction as marker of white matter injury in primary-progressive multiple sclerosis: a longitudinal study. Eur J Neurol. 2019 Aug;26(8):1068-1074.
32) Cellerino M, Cordano C, Boffa G, Bommarito G, Petracca M, Sbragia E, Novi G, Lapucci C, Capello E, Uccelli A, Inglese M. Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS. Neurol Neuroimmunol Neuroinflamm. 2019 Aug 12;6(5).
33) Castro K, Ntranos A, Amatruda M, Petracca M, Kosa P, Chen EY, Morstein J, Trauner D, Watson CT, Kiebish MA, Bielekova B, Inglese M, Katz Sand I, Casaccia P. Body Mass Index in Multiple Sclerosis modulates ceramide-induced DNA methylation and disease course. EBioMedicine. 2019 May;43:392-410.
34) Cocozza S, Pontillo G, Lanzillo R, Russo C, Petracca M, Di Stasi M, Paolella C, Vola EA, Criscuolo C, Moccia M, Lamberti A, Monti S, Brescia Morra V, Elefante A, Palma G, Tedeschi E, Brunetti A. MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis. Neuroradiology. 2019 Feb;61(2):155-162.
35) International Women in MS. Gender Inequities in the Multiple Sclerosis Community: A Call for Action. Ann Neurol. 2018 Dec;84(6):958-959.
36) Cocozza S, Pontillo G, Russo C, Russo CV, Costabile T, Pepe A, Tedeschi E, Lanzillo R, Brescia Morra V, Brunetti A, Inglese M, Petracca M. Cerebellum and cognition in progressive MS patients: functional changes beyond atrophy? J Neurol. 2018 Oct;265(10):2260-2266.
37) Petracca M, Zaaraoui W, Cocozza S, Vancea R, Howard J, Heinig MM, Fleysher L, Oesingmann N, Ranjeva JP, Inglese M. An MRI evaluation of grey matter damage in African Americans with MS. Mult Scler Relat Disord. 2018 Oct;25:29-36.
38) Petracca M, Margoni M, Bommarito G, Inglese M. Monitoring Progressive Multiple Sclerosis with Novel Imaging Techniques. Neurol Ther. 2018 Dec;7(2):265-285.
39) Inglese M, Petracca M. MRI in multiple sclerosis: clinical and research update. Curr Opin Neurol. 2018 Jun;31(3):249-255.
40) Harel A, Sperling D, Petracca M, Ntranos A, Katz-Sand I, Krieger S, Lublin F, Wang Z, Liu Y, Inglese M. Brain microstructural injury occurs in patients with RRMS despite 'no evidence of disease activity'. J Neurol Neurosurg Psychiatry. 2018 Mar 16. [Epub ahead of print]
41) Inglese M, Fleysher L, Oesingmann N, Petracca M. Clinical applications of ultra-high field magnetic resonance imaging in multiple sclerosis. Expert Rev Neurother. 2018 Mar;18(3):221-230.
42) Mormina E, Petracca M, Bommarito G, Piaggio N, Cocozza S, Inglese M. Cerebellum and neurodegenerative diseases: Beyond conventional magnetic resonance imaging. World J Radiol. 2017 Oct 28;9(10):371-388.
43) Petracca M, Sumowski J, Fabian M, Miller A, Lublin F, Inglese M. Looking into cognitive impairment in primary-progressive multiple sclerosis. Eur J Neurol. 2017 Oct 20. ene.13489.
44) Vancea R, Simonyan K, Petracca M, Brys M, Di Rocco A, Ghilardi MF, Inglese M. Cognitive performance in mid-stage Parkinson's disease: functional connectivity under chronic antiparkinson treatment. Brain Imaging Behav. 2017 Sep 23.
45) Cocozza S*, Petracca M*, Mormina E, Buyukturkoglu K, Podranski K, Heinig MM, Pontillo G, Russo C, Tedeschi E, Russo CV, Costabile T, Lanzillo R, Harel A, Klineova S, Miller A, Brunetti A, Morra VB, Lublin F, Inglese M. Cerebellar lobule atrophy and disability in progressive MS. J Neurol Neurosurg Psychiatry. 2017 Dec;88(12):1065-1072.
46) Pardini M, Petracca M, Harel A, Fleysher L, Oesingmann N, Bommarito G, Fabian M, Chard D, Lublin F, Inglese M. The relationship between cortical lesions and periventricular NAWM abnormalities suggests a shared mechanism of injury in primary-progressive MS. Neuroimage Clin. 2017 Jul 4;16:111-115.
47) Poretto V, Petracca M, Saiote C, Mormina E, Howard J, Miller A, Lublin FD, Inglese M. A composite measure to explore visual disability in primary progressive multiple sclerosis. Mult Scler J Exp Transl Clin. 2017 May 18;3(2):2055217317709620.
48) Inglese M, Petracca M, Mormina E, Achiron A, Straus-Farber R, Miron S, Fabian M, Krieger S, Miller A, Lublin F, Sormani MP. Cerebellar volume as imaging outcome in progressive multiple sclerosis. PLoS One. 2017 Apr 24;12(4):e0176519.
49) Petracca M, Saiote C, Bender HA, Arias F, Farrell C, Magioncalda P, Martino M, Miller A, Northoff G, Lublin F, Inglese M. Synchronization and variability imbalance underlie cognitive impairment in primary-progressive multiple sclerosis. Sci Rep. 2017 Apr 21;7:46411.
50) Petracca M, Cordano C, Cellerino M, Button J, Krieger S, Vancea R, Ghassemi R, Farrell C, Miller A, Calabresi PA, Lublin F, Inglese M. Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions? Mult Scler. 2017 Jan;23(1):43-50.
51) Carotenuto A, Iodice R, Petracca M, Inglese M, Cerillo I, Cocozza S, Saiote C, Brunetti A, Tedeschi E, Manganelli F, Orefice G. Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex®. Acta Neurol Scand. 2016 Aug 8.
52) Petracca M, Vancea RO, Fleysher L, Jonkman LE, Oesingmann N, Inglese M. Brain intra- and extracellular sodium concentration in multiple sclerosis: a 7 T MRI study. Brain. 2016 Mar;139(Pt 3):795-806.
53) de Waure C, Di Nardo F, Mazzucco W, Nedovic D, Battaglia MA, Busillo V, Di Iorio W, Gallo A, Lanzillo R, Lombardi E, Maniscalco GT, Orefice G, Petracca M, Romano F, Sinisi L, Spadera AP, Spitaleri D, Vivo P, Ricciardi W. Neurol Sci. 2016 Feb;37(2):315-22. doi: 10.1007/s10072-015-2389-5. Epub 2015 Oct 6.
54) Ruggieri S*, Petracca M*, Miller A, Krieger S, Ghassemi R, Bencosme Y, Riley C, Howard J, Lublin F, Inglese M. Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis. JAMA Neurol. 2015 Dec 1;72(12):1466-74.
55) Carrieri PB, Carbone F, Perna F, Bruzzese D, La Rocca C, Galgani M, Montella S, Petracca M, Florio C, Maniscalco GT, Spitaleri DL, Iuliano G, Tedeschi G, Corte MD, Bonavita S, Matarese G. Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate. Metabolism. 2015 Sep; 64(9):1112-21.
56) Petracca M, Fleysher L, Oesingmann N, Inglese M. Sodium MRI of multiple sclerosis. NMR Biomed. 2015 Apr 6. doi: 10.1002/nbm.3289.
57) Inglese M, Petracca M. Therapeutic strategies in multiple sclerosis: A focus on neuroprotection and repair and relevance to schizophrenia. Schizophr Res. 2015 Jan; 161(1):94-101.
58) Bester M, Petracca M, Inglese M. Neuroimaging of multiple sclerosis, acute disseminated encephalomyelitis, and other demyelinating diseases. Semin Roentgenol. 2014 Jan; 49(1):76-85.
59) Carrieri P, Petracca M, Montella S, Cerullo G, Cerillo I, Cimmino G. Sporadic Porphyria Cutanea Tarda in a Patient with Multiple Sclerosis Treated with Interferon Beta 1-a Therapy: A Case Report. J Clin Neurol. 2013 Jul;9(3):196-7.
60) Petracca M, Cerillo I, Montella S, Cerullo G, Carrieri PB. Idiopathic late-onset cerebellar ataxia with cerebellar atrophy in a patient diagnosed with Chiari I Malformation: a case report. Neurol Sci. 2013 Dec; 34(12):2235-7.
61) Bester M, Lazar M, Petracca M, Babb JS, Herbert J, Grossman RI, Inglese M. Tract-specific white matter correlates of fatigue and cognitive impairment in benign multiple sclerosis. J Neurol Sci. 2013 May 1.
62) Inglese M, Petracca M. Imaging multiple sclerosis and other neurodegenerative diseases. Prion. 2013 Jan 1;7(1):47-54.
63) Carrieri PB, Montella S, Petracca M. Psychiatric onset of multiple sclerosis: description of two cases. J Neuropsychiatry Clin Neurosci. 2011 Spring; 23(2):E6.
64) Carrieri PB, Montella S, Petracca M, Cerullo G, Elefante A. Tolosa-Hunt syndrome in a patient with autoimmune hemolytic anemia. Int J Neurosci. 2010 Oct; 120(10):680-2.
65) Carrieri PB, Montella S, Petracca M. Glossopharyngeal neuralgia as onset of multiple sclerosis. Clin J Pain. 2009 Oct; 25(8):737-9.
66) Carrieri PB, Ladogana P, Di Spigna G, de Leva MF, Petracca M, Montella S, Buonavolontà L, Florio C, Postiglione L. Interleukin-10 and interleukin-12 modulation in patients with relapsing-remitting multiple sclerosis on therapy with interferon-beta 1a: differences in responders and non responders. Immunopharmacol Immunotoxicol. 2008; 30(4):1-9.
67) Carrieri PB, Petracca M, Montella S, Delfino M, Sepe C, Gattoni A. Multiple sclerosis and systemic sclerosis: efficacy of interferon beta on skin lesions. Ann Rheum Dis. 2008 Aug; 67(8):1192-3.
68) Carrieri PB, Petracca M, Montella S. Efficacy of levetiracetam in hemifacial spasm: a case report. Clin Neuropharmacol. 2008 May-Jun;31(3):187-8.
*co-first authors
PUBBLICAZIONI – Monografie e capitoli
1) Inglese M, Petracca M. PET Imaging. Encyclopedia of Clinical Neuropsychology. 2017 Aug 5; Chapter 9080-2 doi:10.1007/978-3-319-56782-2_9080-2.
2) Inglese M, Petracca M. Diffusion Kurtosis Mapping. Encyclopedia of Clinical Neuropsychology. 2017 July 1; Chapter 9079-2 doi:10.1007/978-3-319-56782-2_9079-2.
3) Barone P, Brunetti A, Cappabianca P, Filla A, Gangemi M, Maiuri F, Santoro L, Spaziante R. Sistema Nervoso. Neurologia-Neurochirurgia-Neuroradiologia. ‘Altre patologie demielinizzanti acute del SNC’ Cap.7.2 pp 321-325 Edizioni IDELSON-GNOCCHI 2012.
4) Carrieri PB, Montella S, Petracca M. Neurologia per le professioni sanitarie. Edizioni MEDISERVE, 2009.
INCARICHI EDITORIALI
Revisore per Brain and Cognition, Brain Imaging and Behavior, eNeurological Science, Expert Review of Neurotherapeutics, Fondazione Italiana Sclerosi Multipla (FISM), Frontiers in Neurology, Journal of Neurology, Journal of the Neurological Sciences, Multiple Sclerosis International Journal, Multiple Sclerosis Journal, Multiple Sclerosis and Related Disorders, NeuroImage, Scientific Reports, The Cerebellum, UK MS Society.
Guest Associate Editor in Applied Neuroimaging - Frontiers in Neurology. Review Editor in Neuroradiology -Frontiers in Radiology. Editorial Board Member - BMC Neurology.